Parabilis Medicines, Inc. Deferred Revenue
Parabilis Medicines, Inc. (PBLS) had Deferred Revenue of $10.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-13
- 2026-06-30: Deferred Revenue, Current $10.37M.
- 2025-12-31: Deferred Revenue, Current $0.00.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $10.37M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-13 |